CH469093A - Verfahren zur Herstellung eines neuen Impfstoffes gegen Panleucopenia - Google Patents

Verfahren zur Herstellung eines neuen Impfstoffes gegen Panleucopenia

Info

Publication number
CH469093A
CH469093A CH1439763A CH1439763A CH469093A CH 469093 A CH469093 A CH 469093A CH 1439763 A CH1439763 A CH 1439763A CH 1439763 A CH1439763 A CH 1439763A CH 469093 A CH469093 A CH 469093A
Authority
CH
Switzerland
Prior art keywords
panleucopenia
preparation
vaccine against
new vaccine
new
Prior art date
Application number
CH1439763A
Other languages
English (en)
Inventor
Arthur Slater Eben
John Kucera Carrell
Original Assignee
Philips Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips Nv filed Critical Philips Nv
Publication of CH469093A publication Critical patent/CH469093A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14351—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/819—Viral vaccine for feline species, e.g. cats

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CH1439763A 1962-11-27 1963-11-25 Verfahren zur Herstellung eines neuen Impfstoffes gegen Panleucopenia CH469093A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US240408A US3293130A (en) 1962-11-27 1962-11-27 Panleukopenia vaccine and method for the production thereof

Publications (1)

Publication Number Publication Date
CH469093A true CH469093A (de) 1969-02-28

Family

ID=22906395

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1439763A CH469093A (de) 1962-11-27 1963-11-25 Verfahren zur Herstellung eines neuen Impfstoffes gegen Panleucopenia

Country Status (13)

Country Link
US (1) US3293130A (de)
AT (2) AT248793B (de)
BE (1) BE640495A (de)
BR (1) BR6354820D0 (de)
CH (1) CH469093A (de)
DE (1) DE1198489B (de)
DK (1) DK104899C (de)
ES (1) ES293828A1 (de)
FI (1) FI40922B (de)
FR (1) FR1587309A (de)
GB (1) GB1071922A (de)
NL (2) NL145903B (de)
SE (1) SE334437B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3346456A (en) * 1964-07-01 1967-10-10 Cornell Res Foundation Inc Immunizing pigs against hog cholera with selected strains of live virus diarrhea virus and preparation of virus diarrhea virus hyper-immune hog cholera serum
GB1177635A (en) * 1966-02-18 1970-01-14 Wellcome Found Cell Stains.
US4021302A (en) * 1966-02-18 1977-05-03 Burroughs Wellcome & Co., Inc. Cell cultures
US3892627A (en) * 1973-06-04 1975-07-01 Rohm & Haas Feline panleukopenia vaccine
US4287178A (en) * 1974-03-25 1981-09-01 Pitman-Moore, Inc. Feline rhinotracheitis vaccine and production and use thereof
DE2602478C3 (de) * 1976-01-23 1980-10-09 Behringwerke Ag, 3550 Marburg Impfstoff gegen die Panleukopenie der Feliden
DE2962920D1 (en) * 1978-11-30 1982-07-08 Wellcome Found Attenuated strain of feline infectious peritonitis virus, method for preparing it and vaccine comprising it
US4193990A (en) * 1979-02-16 1980-03-18 Cornell Research Foundation, Inc. Heterotypic canine parvovirus vaccine
US4303644A (en) * 1979-10-16 1981-12-01 Norden Laboratories, Inc. Feline infectious peritonitis virus vaccines
US4303645A (en) * 1980-04-18 1981-12-01 Cornell Research Foundation, Inc. Modified living canine parvovirus vaccine
US4572834A (en) * 1984-04-10 1986-02-25 Clinical Reference Laboratory, Inc. Biologic and method of preparing same

Also Published As

Publication number Publication date
BR6354820D0 (pt) 1973-08-02
FR1587309A (de) 1970-03-20
BE640495A (de) 1964-05-27
US3293130A (en) 1966-12-20
ES293828A1 (es) 1964-02-16
AT248793B (de) 1966-08-10
AT257042B (de) 1967-09-25
GB1071922A (en) 1967-06-14
NL145903B (nl) 1975-05-15
SE334437B (de) 1971-04-26
NL300960A (de)
DK104899C (da) 1966-07-18
FI40922B (de) 1969-03-31
DE1198489B (de) 1965-08-12

Similar Documents

Publication Publication Date Title
CH433333A (de) Verfahren zur Herstellung eines neuen Amins
AT287196B (de) Verfahren zur Herstellung eines neuen Impfstoffes gegen Mastitis
AT253469B (de) Verfahren zur Herstellung eines neuen Katalysators
CH469093A (de) Verfahren zur Herstellung eines neuen Impfstoffes gegen Panleucopenia
AT279816B (de) Verfahren zur Herstellung eines neuen Dekapeptids
AT285065B (de) Verfahren zur Herstellung eines neuen Pentacosapeptids
CH418340A (de) Verfahren zur Herstellung eines neuen Derivats des 1,3-Diazacyclopentens
CH484172A (de) Verfahren zur Herstellung eines neuen Oxazolidinons
AT249266B (de) Verfahren zur Herstellung eines neuen Sulfomethyl-Polymyxins
AT249885B (de) Verfahren zur Herstellung eines neuen Hexapeptids
CH466894A (de) Verfahren zur Herstellung eines Vakzins gegen infektiöse Gastroenteritis
AT262994B (de) Verfahren zur Herstellung eines neuen Phenylbutazonderivates
CH471782A (de) Verfahren zur Herstellung eines neuen, substituierten 2,3-Pyridindiols
AT279038B (de) Verfahren zur Herstellung eines Impfstoffes gegen Röteln
CH444158A (de) Verfahren zur Herstellung eines neuen Bis-pyridyl-methyl-disulfids
CH376897A (de) Verfahren zur Herstellung eines neuen Sulfonylharnstoffs
AT250953B (de) Verfahren zur Herstellung von neuen tertiärer Carbamyltriazole
CH464949A (de) Verfahren zur Herstellung eines neuen Hendekapeptids
AT262260B (de) Verfahren zur Herstellung eines neuen Thiamphenikol-Derivates
CH420182A (de) Verfahren zur Herstellung eines neuen Pyrazolo-pyrimidin-Derivates
AT252471B (de) Verfahren zur Herstellung eines neuen Bis-pyridyl-methyl-disulfids
AT241458B (de) Verfahren zur Herstellung eines neuen Oxadiazolinderivates
CH420197A (de) Verfahren zur Herstellung eines neuen mitosehemmenden Präparates
CH475271A (de) Verfahren zur Herstellung eines neuen Oxazinderivates
AT253147B (de) Verfahren zur Herstellung eines neuen Nonadekapeptids